Challenges and Opportunities in Using Residual Newborn Screening Samples for Translational Research

Workshop Summary

Häftad, Engelska, 2010

Av Roundtable on Translating Genomic-Based Research for Health, Board on Health Sciences Policy, Institute of Medicine, Institute Of Medicine, Board On Health Sciences Policy, Adam C. Berger, Steve Olson

449 kr

Tillfälligt slut

Newborn screening samples are used to test more than 4 million infants each year for life-threatening diseases that are treatable if found at birth. These specimens also represent a potentially invaluable resource for public health and biomedical research. The IOM held a workshop to examine issues surrounding the use of residual specimens for translational research.

Produktinformation

Utgivningsdatum2010-12-23
Mått152 x 229 x undefined mm
FormatHäftad
SpråkEngelska
Antal sidor84
FörlagNational Academies Press
ISBN9780309159548

Tillhör följande kategorier

Medicinsk utrustning och medicinska tekniker inom Medicin

1 Front Matter; 2 1 Introduction; 3 2 Newborn Screening as a Public Health Program; 4 3 Uses of Residual Newborn Screening Samples in Research; 5 4 Concerns About the Use of Residual Newborn Screening Samples; 6 5 Review and Consent in the Use of Residual Newborn Screening Samples; 7 6 Parental and Public Education; 8 7 Workshop Overview and Wrap-Up; 9 References; 10 Appendix A: Workshop Agenda; 11 Appendix B: Speaker Biographical Sketches

Mer från samma författare

Diffusion and Use of Genomic Innovations in Health and Medicine

Diffusion and Use of Genomic Innovations in Health and Medicine

Roundtable on Translating Genomic-Based Research for Health, Board on Health Sciences Policy, Institute of Medicine, Institute Of Medicine, Board On Health Sciences Policy, Lyla M. Hernandez

619 kr

Innovations in Service Delivery in the Age of Genomics

Innovations in Service Delivery in the Age of Genomics

Board on Health Sciences Policy, Roundtable on Translating Genomic-Based Research for Health, Institute of Medicine, Institute Of Medicine, Board On Health Sciences Policy, Erin Hammers

449 kr

Systems for Research and Evaluation for Translating Genome-Based Discoveries for Health

Systems for Research and Evaluation for Translating Genome-Based Discoveries for Health

Institute of Medicine, Board on Health Sciences Policy, Roundtable on Translating Genomic-Based Research for Health, Institute Of Medicine, Board On Health Sciences Policy, Theresa Wizemann

589 kr

Value of Genetic and Genomic Technologies

Value of Genetic and Genomic Technologies

Institute of Medicine, Board on Health Sciences Policy, Roundtable on Translating Genomic-Based Research for Health, Institute Of Medicine, Board On Health Sciences Policy, Adam C. Berger, Theresa Wizemann

619 kr

Establishing Precompetitive Collaborations to Stimulate Genomics-Driven Product Development

Establishing Precompetitive Collaborations to Stimulate Genomics-Driven Product Development

Institute of Medicine, Board on Health Sciences Policy, Roundtable on Translating Genomic-Based Research for Health, Institute Of Medicine, Board On Health Sciences Policy, Adam C. Berger, Steve Olson

449 kr

Generating Evidence for Genomic Diagnostic Test Development

Generating Evidence for Genomic Diagnostic Test Development

Institute of Medicine, Board on Health Sciences Policy, Roundtable on Translating Genomic-Based Research for Health, Institute Of Medicine, Board On Health Sciences Policy, Adam C. Berger, Theresa Wizemann

449 kr

Integrating Large-Scale Genomic Information into Clinical Practice

Integrating Large-Scale Genomic Information into Clinical Practice

Roundtable on Translating Genomic-Based Research for Health, Board on Health Sciences Policy, Institute of Medicine, Institute Of Medicine, Board On Health Sciences Policy, Steve Olson, Sarah H. Beachy, Claire Giammaria, Adam C. Berger

579 kr

Genome-Based Diagnostics

Genome-Based Diagnostics

Institute of Medicine, Board on Health Sciences Policy, Roundtable on Translating Genomic-Based Research for Health, Institute Of Medicine, Board On Health Sciences Policy, Adam C. Berger, Steve Olson

549 kr

Genome-Based Therapeutics

Genome-Based Therapeutics

Institute of Medicine, Board on Health Sciences Policy, Roundtable on Translating Genomic-Based Research for Health, Institute Of Medicine, Board On Health Sciences Policy, Steve Olson, Adam C. Berger

539 kr

Du kanske också är intresserad av

Genome-Based Diagnostics

Genome-Based Diagnostics

Center for Medical Technology Policy, Institute of Medicine, Board on Health Sciences Policy, Roundtable on Translating Genomic-Based Research for Health, Institute Of Medicine, Board On Health Sciences Policy, Steve Olson, Adam C. Berger

589 kr

Genome-Based Diagnostics

Genome-Based Diagnostics

Institute of Medicine, Board on Health Sciences Policy, Roundtable on Translating Genomic-Based Research for Health, Institute Of Medicine, Board On Health Sciences Policy, Adam C. Berger, Steve Olson

549 kr

Improving Genetics Education in Graduate and Continuing Health Professional Education

Improving Genetics Education in Graduate and Continuing Health Professional Education

Institute of Medicine, Board on Health Sciences Policy, Roundtable on Translating Genomic-Based Research for Health, Institute Of Medicine, Board On Health Sciences Policy, Steve Olson, Sarah H. Beachy, Samuel G. Johnson, Adam C. Berger

649 kr

Drug Repurposing and Repositioning

Drug Repurposing and Repositioning

Institute of Medicine, Board on Health Sciences Policy, Roundtable on Translating Genomic-Based Research for Health, Institute Of Medicine, Board On Health Sciences Policy, Adam C. Berger, Steve Olson, Samuel G. Johnson, Sarah H. Beachy

589 kr

Assessing Genomic Sequencing Information for Health Care Decision Making

Assessing Genomic Sequencing Information for Health Care Decision Making

Institute of Medicine, Board on Health Sciences Policy, Roundtable on Translating Genomic-Based Research for Health, Institute Of Medicine, Board On Health Sciences Policy, Adam C. Berger, Steve Olson, Samuel G. Johnson, Sarah H. Beachy

679 kr

Establishing Precompetitive Collaborations to Stimulate Genomics-Driven Product Development

Establishing Precompetitive Collaborations to Stimulate Genomics-Driven Product Development

Institute of Medicine, Board on Health Sciences Policy, Roundtable on Translating Genomic-Based Research for Health, Institute Of Medicine, Board On Health Sciences Policy, Adam C. Berger, Steve Olson

449 kr

Improving the Efficiency and Effectiveness of Genomic Science Translation

Improving the Efficiency and Effectiveness of Genomic Science Translation

Institute of Medicine, Board on Health Sciences Policy, Roundtable on Translating Genomic-Based Research for Health, Institute Of Medicine, Board On Health Sciences Policy, Adam C. Berger, Steve Olson, Samuel G. Johnson, Sarah H. Beachy

579 kr

Conflict of Interest and Medical Innovation

Conflict of Interest and Medical Innovation

Institute of Medicine, Board on Health Sciences Policy, Roundtable on Translating Genomic-Based Research for Health, Institute Of Medicine, Board On Health Sciences Policy, Steve Olson, Adam C. Berger, Sarah H. Beachy

609 kr

Refining Processes for the Co-Development of Genome-Based Therapeutics and Companion Diagnostic Tests

Refining Processes for the Co-Development of Genome-Based Therapeutics and Companion Diagnostic Tests

Institute of Medicine, Board on Health Sciences Policy, Roundtable on Translating Genomic-Based Research for Health, Institute Of Medicine, Board On Health Sciences Policy, Adam C. Berger, Steve Olson, Samuel G. Johnson, Sarah H. Beachy

549 kr

Genome-Based Therapeutics

Genome-Based Therapeutics

Institute of Medicine, Board on Health Sciences Policy, Roundtable on Translating Genomic-Based Research for Health, Institute Of Medicine, Board On Health Sciences Policy, Steve Olson, Adam C. Berger

539 kr